BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 16159019)

  • 1. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
    Kent T; McAlpine C; Sabetnia S; Presland J
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):580-9. PubMed ID: 17786857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.
    Breitwieser GE
    Circ Res; 2004 Jan; 94(1):17-27. PubMed ID: 14715532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling mechanisms of GPCR ligands.
    Strange PG
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):196-202. PubMed ID: 18283607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways.
    Rovira X; Pin JP; Giraldo J
    Trends Pharmacol Sci; 2010 Jan; 31(1):15-21. PubMed ID: 19963287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
    Panetta R; Greenwood MT
    Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRIP: a server for predicting interfaces for GPCR oligomerization.
    Nemoto W; Fukui K; Toh H
    J Recept Signal Transduct Res; 2009 Dec; 29(6):312-7. PubMed ID: 19888901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I want a new drug: G-protein-coupled receptors in drug development.
    Schlyer S; Horuk R
    Drug Discov Today; 2006 Jun; 11(11-12):481-93. PubMed ID: 16713899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization in GPCR mobility and signaling.
    Lohse MJ
    Curr Opin Pharmacol; 2010 Feb; 10(1):53-8. PubMed ID: 19910252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based assays in GPCR drug discovery.
    Siehler S
    Biotechnol J; 2008 Apr; 3(4):471-83. PubMed ID: 18383022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel roles for arrestins in G protein-coupled receptor biology and drug discovery.
    Claing A; Laporte SA
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):585-9. PubMed ID: 16159020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
    Huber T; Menon S; Sakmar TP
    Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of oligomers by G protein-coupled receptors.
    Gazi L; López-Giménez JF; Strange PG
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):756-63. PubMed ID: 12630296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.